"Taking cognisance of this, the state government has ordered that all drug production at this unit be stopped with immediate effect," Vij told PTI over phone.
The report of the samples of four cough syrups which had been recently sent to the Central Drugs Laboratory in Kolkata for examination was awaited.
'Shocked, deeply saddened,' says Maiden pharma after WHO alert on its cough syrups links to child deaths in Gambia
The world body had also said syrups have been "potentially linked with acute kidney injuries and 66 deaths among children.”
Dr Gupta said the first death suspected to be due to the same reason was noted in July.
WHO recently warned that four "contaminated" cough syrups allegedly produced by Maiden Pharmaceuticals Ltd based in Sonipat could be behind the deaths of 66 Gambian children.
The cough syrup by New Delhi-based Indian pharmaceutical company Maiden Pharmaceuticals is not sold in India but is being exported.
"Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants," the WHO said.